PROSCIA INC

Proscia Inc. specializes in the development and deployment of advanced digital pathology and imaging management systems, with a core focus on AI-powered software solutions for biomedical research and clinical diagnostics. Their flagship Concentriq Imaging Management System enables secure, scalable handling of whole-slide digital pathology data, supporting workflow automation, image analysis, and collaborative research across distributed healthcare and scientific environments. Technical expertise includes enterprise-grade imaging platform architecture, HIPAA-compliant data governance, cloud-native deployment models, and integration with laboratory information systems. Proscia’s differentiation lies in its domain-specific focus on computational pathology, delivering FDA-recognized tools that enhance diagnostic accuracy and accelerate tissue-based research. The company maintains a strong relationship with the Department of Health and Human Services, providing mission-critical imaging software for public health research and regulatory science initiatives. It also supports federal procurement through the General Services Administration’s Federal Supply Schedule, ensuring streamlined access to its certified imaging platform across civilian and defense agencies. These engagements reflect a pattern of trusted, repeat partnerships centered on secure, scalable software delivery for health data infrastructure. Proscia operates primarily under NAICS 513210, classifying it as a software publisher focused on specialized medical and scientific applications. Its market positioning is niche yet strategic, serving the intersection of digital pathology, artificial intelligence in healthcare, and government-funded biomedical research. The company’s solutions are tailored for laboratories, research institutions, and federal health agencies requiring robust, compliant imaging platforms. Proscia Inc. is a privately held entity based in Philadelphia, Pennsylvania, with no federal certifications on record. Its government market presence is anchored in delivering specialized software to health-focused federal clients through direct contracts and GSA channels, establishing itself as a trusted provider of mission-critical diagnostic imaging technology.